Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000708019 | SCV000837129 | pathogenic | Aniridia 1; Irido-corneo-trabecular dysgenesis | 2019-03-29 | criteria provided, single submitter | clinical testing | A gross deletion of the genomic region encompassing the full coding sequence of the PAX6 gene has been identified. The boundaries of this event are unknown as the deletion extends beyond the assayed region for this gene and therefore may encompass additional genes. Deletion of the PAX6 gene has been reported in individuals affected with aniridia (PMID: 27124303, 26661695). In addition, it has been reported as part of a larger deletion with the WT1 gene in individuals affected with WAGR syndrome (PMID: 17630404, 24138039). Loss-of-function variants in PAX6 are known to be pathogenic (PMID: 12634864). For these reasons, this variant has been classified as Pathogenic. |
Labcorp Genetics |
RCV001386651 | SCV001586959 | pathogenic | Drash syndrome; Frasier syndrome; Wilms tumor 1; 11p partial monosomy syndrome | 2020-07-24 | criteria provided, single submitter | clinical testing | A gross deletion of the genomic region encompassing the full coding sequence of the WT1 gene has been identified. The boundaries of this event are unknown as the deletion extends beyond the assayed region for this gene and therefore may encompass additional genes. Deletion of the WT1 gene has been reported in an individual affected with Wilms tumor and developmental structural anomalies of the genitourinary tract (PMID: 15150775). In addition, it has been reported as part of a larger deletion with the PAX6 gene in individuals affected with WAGR syndrome (PMID: 17630404, 24138039) Loss-of-function variants in WT1 are known to be pathogenic (PMID: 15150775). For these reasons, this variant has been classified as Pathogenic. |